BrightInsight delivers a cloud-based platform that enables life-science companies to rapidly develop, launch, and scale compliant digital health solutions such as patient companion apps, digital-first patient support programs, and Software as a Medical Device tools. Its technology captures real-world data and helps pharmaceutical partners differentiate flagship therapies while improving medication adherence and persistence. The company supports initiatives like the Patient App created in collaboration with Sanofi and Regeneron and aims to expand these offerings across a broad range of diseases and therapies globally. BrightInsight’s roadmap includes further AI-enabled features to enhance medication-persistence analytics. Led by CEO Kal Patel and headquartered in San Jose, CA, the firm works with biopharma customers worldwide to deliver measurable clinical and business value through digital interventions.

Total raised

$179M

Funding rounds

4

Latest round

Equity

Latest activity

Jan 2026